Health care should first and foremost be about patients. Yet in Malaysia’s rapidly expanding private health care sector, an uncomfortable question needs to be asked: who is protecting the consumer?
Private hospitals are businesses. Their survival depends on revenue growth and profitability. But the incentives of a profit-driven system can easily clash with the core principle of medicine — to treat only what is necessary and in the best interest of the patient.
In any commercial environment, doing more usually means earning more. More tests, more procedures, more admissions, and more treatments all translate into higher bills.
For patients, this raises a legitimate concern: are all treatments always necessary, or are financial incentives quietly shaping medical decisions?
The situation becomes even more complicated because patients rarely approach hospitals from a position of strength. They are often sick, anxious, in pain, or worried about a loved one.
During such moments, people are not at their best mental or emotional state. They are vulnerable and naturally inclined to trust the advice of medical professionals without question.
This imbalance of knowledge and emotional stress makes it even more important that strong safeguards exist to protect patients from unnecessary procedures or excessive costs.
At the same time, preventive care — which keeps people healthy and reduces long-term health care costs — often receives far less attention.
Prevention rarely generates the same financial returns as treatment. As a result, health care systems tend to reward curing disease rather than preventing it.
Malaysia is already facing a growing health crisis. With over half the population overweight or obese, and with rising rates of diabetes and cardiovascular disease, the need for prevention has never been greater. Yet the health care industry’s economic structure continues to favour curative care.
Patients are also increasingly shocked by the size of hospital bills. Without clear pricing transparency or a strong consumer protection framework, many patients are left wondering whether they truly have a choice — or whether they are simply following recommendations they feel unable to question.
Private health care will remain an essential part of Malaysia’s health system. But if costs continue to rise without stronger safeguards for consumers, public trust will inevitably be tested.
It is therefore time for policymakers, regulators and the medical profession to address a fundamental question:
In a profit-driven health care environment, who ensures that the patient always comes first? A serious national conversation on this issue can no longer be avoided.
The author is an actuary, national tower-running athlete, and patient advocate for transplant and blood donation.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
